Table 1. Patient demographics and clinical data.
| CTRL, n = 10 | HCVR, n = 20 | |
| Age, yrs | 55.3 ± 2.2 | 56.0 ± 1.5 |
| BMI, kg/m2 | 25.2 ± 1.5 | 30.3 ± 1.7* |
| Systolic blood pressure, mmHg | 124.9 ± 3.3 | 120.0 ± 2.5 |
| Diastolic blood pressure, mmHg | 82.3 ± 2.4 | 83.5 ± 3.2 |
| Total cholesterol, mg/dL | 200.3 ± 2.6 | 210.5 ± 1.5 |
| HDL, mg/dL | 73.2 ± 4.0 | 44.9 ± 3.2 |
| C-reactive protein, mg/dL | < 2 | < 2 |
| Glucose, mg/dL | 93.7 ± 5.3 | 90.2 ± 6.7 |
| Creatinine, mg/dL | 1.1 ± 0.3 | 1.0 ± 0.2 |
| AST, U/L | 19.2 ± 8.1 | 22.4 ± 5.3 |
| ALT, U/L | 16.5 ± 6.2 | 22.1 ± 7.4 |
| Gamma-GT, U/L | 32.3 ± 5.1 | 29.6 ± 10.3 |
| Alkaline phosphatase, mU/mL | 112 ± 34 | 89 ± 56 |
| Total bilirubin, mg/dL | 0.73 ± 0.1 | 0.69 ± 0.2 |
| Albumin, g/L | 3.9 ± 0.2 | 3.8 ± 0.1 |
| Treatment for hypertension | ||
| Ca2+ channel blockers | 0 | 12 |
| β-blockers | 0 | 10 |
| ACEI | 0 | 12 |
| Cigarette smokers | 0 | 0 |
| Alcohol drinking | 0 | 0 |
Values are mean ± SD. *P < 0.001. ACEI: angiotensin-converting enzyme inhibitors; ALT: alanine aminotransferase; AST: aspartate aminotransferase; BMI: body mass index; HDL: high-density lipoprotein.